Mariscal-Uriarte J, Martínez-Baca F, Rosas-Munive E

Language: Spanish
References: 26
Page: 154-159
PDF size: 247.00 Kb.

ABSTRACT

Objective: To report our experience with the use of Levovist in echocardiogragphic studies. Method: We studied consecutively patients with suboptimal echocardiographic studies. A bolus of 4 gr &#@ 400 mg/ml was administered via antecubital vein and a second echocardiogram was performed during the ensuing minutes. Results: Between June and July 1998 we studied 16 patients with suboptimal echocardiograms, seven males and nine females, ages 29-77. There were six patients with coronary artery disease (CAD), three with mitral regurgitation (MR), one with dynamic subaortic stenosis, five with right chambers dilatation and one with a left atrial tumor. No patient referred discomfort or had any complication-with Lovevist. The mean time of the contrast effect was nine minutes. A better delineation of endocardial borders was observed this allowed better evaluation of wall motion and left ventricular function in patients with CAD. There was Doppler enhancement in patients with MR and subaortic stenosis facilitating its evaluation. We documented atrial septal defect non visualized previously in two of five patients with right chambers dilatation. There was a better delineation of the left atrial tumor. Conclusions: Levovist showed enhancement of all Doppler modalities and facilitated de evaluation of MR, left ventricular function, subaortic stenosis and a cardiac tumor. It was safe and well tolerated.

REFERENCES

1. Feigenbaum H: Instrumentación. En: Feigenbaum H. Ecocardiografía. 5ª Ed. Filadelfia. Panamericana 1994; 1-66.

2. Taylor KJ: Current Status of Toxicity Investigation. J Clin Ultrasound 1974; 2: 149-156.

3. Edle L, Gustafson A, Karlefore T, Christonsson B: Ultrasound Cardiography. Acta Med Scand 1961; 370(Suppl): 68-82.

4. Lehman J: The Biophtsical Basis of Biological Ultrasonic Reaction with Special Reference to Ultrasonic Therapy. Arch Phys Med Rehabil 1953; 34: 139-152.

5. Skorton DJ, Collins SM, Greenleaf JF, Meltzer RS, O' Brian Jr WD, Schnittger F, et al: Ultrasound Dioeffect and Regulatory Issues: An Introduction for the Echocardiography. J Am Soc Echocardiogr 1988; 1: 240-251.

6. Carstensen EL, Duck FA, Metzer RS, Schwarz KQ, Keller B: Bioeffects in Echocardiography. Echocardiography 1992; 9: 605-623.

7. Seward JB, Khandheria BK, Oh JK, Abel MD, Hughes RW, Edwards WO, et al: Transesophageal Echocardiography: Technique. Anatomic Correlations. Implementation, and Clinical Applications. Mayo Clin Proc 1988; 63: 649-680.

8. Schiller NB, Maurer G, Ritter SB, Armstrong WF, Crawford M, Sportnitz H, et al: Transesophageal Echocardiography. J Am Soc Echocardiogr 1989; 2: 354-357

9. Gramiak R, Shah P: Echocardiography of the aortic root. Investigative Radiology 1968; 3: 356-366.

10. Gramiak K, Shah P, Kramer D: Ultrasound echocardigraphy: Contrast Study in Anatomy and Function. Radiology 1969; 92: 939-948.

11. Kremkau FW, Gramiak R, Cartensen E, Shah PM, Kramer DH: Ultrasonic Detection of Cavitation at Catheter Tips. Am J Roentgenol 1970; 110: 177-183.

12. Feingenbaum H, Stone J, Lee D, Nasser W, Chan S: Identification of Ultrasound Echoes from the Left Ventricule by use of Intracardiac Inyections of Indocyanine Green. Circulation 1970; 41: 615-621.

13. Brommer W, Shah L, Caldwell R, Hurwitz R, Dillon J, Feingenbaum H: Negative Contrast Echocardiography: A New Method for Detecting Left to Rigth Shunts. Circulation 1979; 59: 498-505.

14. Freintein S, Ten C, Zwehl W, Ong K, Maurer G, Tei C, et al: Two-Dimensional Contrast Agents. J Am Coll Cardiol 1984; 3: 14-20.

15. Tei C, Kondo S, Meerbaum S, Ong K, Jaurer G, Wood F, et al: Correlation of Myocardial Echocontrast Disappearance rate (Washout) and severity of experimental Coronary Stenosis. J Am Coll Cardiol 1984; 3: 39-40.

16. Dolan M, Vrain J, Castello R, Flanagan J, Puri S, Havens E, et al: Comparison of Second Harmonic Power Imaging and Fundamental Imaging During Albumex Administration on Left Ventricular Opacification (Abstr). J Am Soc Echocardiogr 1997; 10: 415.

17. Porter T, Shouping G, Kriesfeld D, Armbruster R: Detection of Myocardial Perfusion in Multiple Echocardiographic Windows With One Intravenous Injection of Microbubles Using Transient Reponse Second Harmonic Imaging. J Am Coll Cardiol 1997; 29: 791-799.

18. Becher H: Harmonic Power Doppler Contrast Echocardiography. Preliminary Clinical results. Am J Echocardiogr 1997; 14: 637-642.

19. Porter TR, Xie F, Li S. Difference in Myocardial Contrast Produced With Transient Response Imaging When Using Intravenous Microbubbles Containing Gases of Different Molecular Weight. Echocardiography 1997; 14: 441-446.

20. Falcone R, Marcowitz P, Pérez J, Dittrich H, Hopkins W, Armstrong W: Intravenous During Dobutamine Stress Echocardiography: Enhanced Localization of Left Ventricular Endocardial Borders. Am Heart J 1995; 130: 254-258.

21. Neudert J, Sutherland G, Von Bibra H, Becher H, Nihoyannopoulos P, Autenrieth G: Contrast Enhanced Doppler Echocardiography for the Evaluation of Aortic Valva Disease (Abstr). Echocardiography 1993; 10: 673.

22. Von Bibra H, Firschke C, Neumann M, Horcher J, Schömig A: Contrast Enhanced Doppler Echocardiography Improve the Transthoracic Evaluation of Mitral Regurgitation and Pulmonary Venous Flow (Abstr). Echocardiography 1993; 10: 672.

23. Nihoyannopoulos P: Contrast Echocardiograpy. Clin Radiol 1996; 51(Suppl 1): 28-30.

24. Von Bibra H, Becher H, Firschke C, Schlief R, Emslander HP, Schömig A: Enhancement of Mitral Regurgitation and Normal Left Atrial Color Doppler Flow Signal with Peripheral Venous Injection of a Saccharide-Based Contrast Agent. J Am Coll Cardiol 1993; 22: 521-528.

25. Schlief R: Levovist Improves Mitral Regurgitation Diagnosis (Abstr). Clinica 1991; 459: 23.

26. Tuchnitz A, Von Bibra H, Sutherland GR, Erbardt W, Henke J, Schömig A: Doppler Energy: A new acquisition technique for the transthoracic detection of myocardial perfusion defects with the use of a venous contrast agent. J Am Soc Echocardiogr 1997; 10: 881-90.